NCT05928169Recruiting
Determinants of Chronic Inflammatory Skin Disease Trajectories
Source: ClinicalTrials.gov · Last updated 28 Aug 2026
Brief summary (registry, in English)
Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 1 Jun 2023
- Start date
- May 2023
- Primary completion date
- Apr 2032
- Lead sponsor
- University Hospital Schleswig-Holstein
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT05928169
What you commit to
- Study type: Observational
- Planned participants: 1000
- From May 2023 to the primary completion date, Apr 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concurrent participation in a clinical trial
- use of systemic immunosuppressive therapy or phototherapy during the last 4 weeks or receipt of biologics therapy (e.g. dupilumab, tralokinumab) within the last 3 months
- treatment of the target skin areas with topical corticosteroids, calcineurin inhibitors or emollients 24 hours before sample collection
Other
- subject and/or the legal guardians are not able to give written informed consent
- pregnant and breastfeeding women
Who the study is looking for
- dermatologist-diagnosed inflammatory skin disease
- informed consent
Age in the registry: 0 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Dermatology and Allergy, University Hospital Schleswig-Holstein Coordinator of this site? Confirm its status | Kiel | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.